14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $3.13 $4.97 Wednesday, 1st May 2024 ALDX stock ended at $4.20. This is 6.60% more than the trading day before Tuesday, 30th Apr 2024. During the day the stock fluctuated 8.46% from a day low at $3.96 to a day high of $4.30.
90 days $2.71 $4.97
52 weeks $1.42 $11.97

Historical Aldeyra Therapeutics prices

Date Open High Low Close Volume
Dec 09, 2021 $7.18 $7.43 $7.03 $7.05 460 426
Dec 08, 2021 $7.40 $7.54 $7.26 $7.32 434 262
Dec 07, 2021 $6.72 $7.51 $6.72 $7.33 1 094 083
Dec 06, 2021 $6.91 $7.01 $6.57 $6.89 591 595
Dec 03, 2021 $7.32 $7.40 $6.80 $6.89 673 324
Dec 02, 2021 $7.47 $7.56 $7.13 $7.33 676 840
Dec 01, 2021 $7.78 $7.99 $7.35 $7.38 1 079 197
Nov 30, 2021 $7.13 $7.79 $6.97 $7.67 921 990
Nov 29, 2021 $7.79 $7.86 $7.13 $7.16 1 130 425
Nov 26, 2021 $8.25 $8.25 $7.32 $7.68 693 280
Nov 24, 2021 $7.83 $8.00 $7.66 $7.92 427 265
Nov 23, 2021 $8.01 $8.11 $7.71 $7.92 574 363
Nov 22, 2021 $8.02 $8.05 $7.72 $7.96 945 603
Nov 19, 2021 $8.11 $8.30 $7.84 $7.93 490 289
Nov 18, 2021 $8.23 $8.40 $7.95 $8.16 571 408
Nov 17, 2021 $8.51 $8.62 $8.23 $8.25 492 914
Nov 16, 2021 $8.57 $8.70 $8.47 $8.61 329 465
Nov 15, 2021 $8.83 $8.97 $8.62 $8.66 376 171
Nov 12, 2021 $9.04 $9.06 $8.74 $8.82 317 960
Nov 11, 2021 $9.12 $9.35 $8.84 $8.96 434 666
Nov 10, 2021 $9.12 $9.34 $8.93 $9.09 456 551
Nov 09, 2021 $9.09 $9.40 $8.97 $9.25 638 045
Nov 08, 2021 $9.05 $9.45 $8.91 $9.11 664 900
Nov 05, 2021 $9.24 $9.32 $8.83 $8.94 492 931
Nov 04, 2021 $9.61 $9.69 $9.15 $9.24 411 835
Click to get the best stock tips daily for free!

About Aldeyra Therapeutics

Aldeyra Therapeutics Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It also develops ADX-629, a first-in-class orally administered RASP modulator that is Phase II clinical tria... ALDX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT